Please login to the form below

Not currently logged in
Email:
Password:

mis-marketing

This page shows the latest mis-marketing news and features for those working in and with pharma, biotech and healthcare.

Double win for J&J's schizophrenia franchise

Double win for J&J's schizophrenia franchise

Johnson &Johnson (J&J) will not have to pay a $1.2bn penalty for alleged mis-selling of its schizophrenia drug Risperdal in the US, according to a court ruling. ... Two years ago, a $1.2bn fine was levied on J&J and its Janssen Pharma unit after a jury

Latest news

  • Takeda CEO admits to Blopress mis-marketing Takeda CEO admits to Blopress mis-marketing

    Takeda CEO admits to Blopress mis-marketing. Campaign used graph indicating drug was superior to Pfizer’ s Norvasc. ... The mis-marketing stemmed from a trial initially reported at a medical conference in 2006 and subsequently published in the journal

  • J&J to pay $181m to settle Risperdal off-label promotion lawsuits in the US J&J to pay $181m to settle Risperdal off-label promotion lawsuits in the US

    Company's Janssen subsidiary looks to draw a line under mis-marketing claims filed in 36 US states. ... J&J also paid a settlement charge of $158m to the state of Texas in January, 2012, for a case that again involved allegations concerning the marketing

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics